| Name | Title | Contact Details |
|---|
A national thought leader on the conversation around aging in America, Parker currently has locations throughout New Jersey in Highland Park, New Brunswick, Monroe Township, Somerset and Piscataway. Parker has a vibrant history of person-centered, long-term care, with a special focus on quality of life. We offer these services and provide subsidized support to people across a range of abilities and needs, in our residences and communities. Instead of focusing on what the culture tells us we can`t do as we grow older, Parker focuses on what we want to do more of. Since 1907, Parker has led the way in aging services - challenging, changing, and expanding the idea of what it means to grow older in America - and how everyone can be #WithIt.
Applied Medical Services is a Durham, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Mind Cure is a mental health and wellness company with a mission to identify, develop and commercialize products that ease suffering, increase productivity, and enhance mental health. It is the therapeutic potential of nootropics, psychoactive products, and psychedelic substances to treat the profound distress of a world suffering from a mental health crisis that led to the formation of Mind Cure.
Ampio is an innovative drug discovery and development company combining scientific, regulatory, and business capabilities to efficiently develop a robust portfolio of novel therapeutic candidates. These therapeutic candidates, if approved, will address significant inflammatory conditions for which limited treatment options exist. Ampio’s therapeutic product pipeline has been developed through more than two decades of study at leading hospital-based research centers. Rigorous preclinical and clinical research efforts have yielded a diverse portfolio of late-stage product candidates focusing on the world’s most prevalent inflammatory conditions including osteoarthritis and diabetic macular edema. Significant discoveries in both basic science and clinical research have resulted in Ampio receiving over 180 patents throughout the world, with hundreds more pending. Further, hundreds of peer-reviewed publications, abstracts, and scientific presentations highlight the depth of research supporting Ampio’s therapeutic product candidates. Ampio’s leading product candidates are Ampion™ and Optina™. The company is currently conducting the second pivotal clinical trial in the US for Ampion, a biologic intra-articular injection being studied for the treatment of osteoarthritis of the knee. Ampio is also conducting a late-stage US clinical trial for Optina, an oral agent being studied for the treatment of diabetic macular edema. Millions of patients worldwide are affected by these conditions, for which limited treatment options exist. At Ampio, we strive to offer compelling therapeutic options for the patients most in need of new treatments, and we operate every day to advance our products’ development and make these available to patients.